Loading company…
ShanX Medtech develops rapid antimicrobial susceptibility tests that help healthcare providers select antibiotic treatments.
ShanX Medtech develops ultra-rapid antimicrobial susceptibility testing diagnostics for hospitals, laboratories, and healthcare providers. Its platform is designed to identify bacterial infections and provide test results within one hour. Founded in 2019, the company is based in Eindhoven, Netherlands. In December 2025, it raised EUR 15 million in seed funding co-led by StartGreen Capital, NextGen Ventures, BOM Brabant Ventures, CbusineZ, and Invest-NL.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in